
CLINICAL AND MOLECULAR DATA ON
MENTAL RETARDATION IN BULGARIA Todorov T1#, Todorova A1#, Avdjieva D2, Dimova P3,
Angelova L4, Tincheva R2 and Mitev V1 *Corresponding Author: Tihomir Todorov, Department of Medical Chemistry and Biochemistry,
Sofia Medical University, 2 “Zdrave” str., Sofia 1431, Bulgaria; Tel./Fax: +359 29530715;
tisho.todorov@abv.bg page: 11
|
PROTOCOLS FOR SNRPN GENE ANALYSIS
Methylation-Specific PCR. DNA was
modified by bisulfite treatment using MethylCode
Bisulfite Conversion Kit (Invitrogen, Carlsbad, CA,
USA), following the manufacturer’s instructions.
The standard protocol was used to amplify maternal
methylated and paternal unmethylated alleles [15].
The amplicons were separated in 3% agarose gel
and visualized after ethidium bromide staining.
The lack of paternal unmethylated fragment (164
bp) leads to PWS, the lack of maternal methylated
fragment (131 bp) leads to AS.
Methylation-Sensitive MLPA (MS-MLPA).
The MS-MLPA (SALSA MS-MLPA ME028-A1
Prader-Willi/ Angelman probemix) was performed
following the manufacturer’s instructions [14]. This
test is performed as a CNT and a MT in presence
of methylation-sensitive restriction enzyme HhaI
(Pharmacia Biotech). The protocol is as described
above for FMR1 gene. The HhaI cleaves only
unmethylated genomic DNA. If the CpG islands
are methylated, the HhaI does not digest them;
the fragment is amplified by PCR and detected
by capillary electrophoresis. If the CpG sites
are unmethylated, there is no PCR product in the
electrophoretic profile. The CNT permits detection
of deletions in PWS/AS cases, while the MT permits
clarification of UPD in PWS, as two maternal
methylated alleles are present.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|